TELCON RF PHARMACEUTICAL. Statistics

Total Valuation

KOSDAQ:200230 has a market cap or net worth of KRW 36.92 billion. The enterprise value is 82.88 billion.

Market Cap	36.92B
Enterprise Value	82.88B

Important Dates

The last earnings date was Friday, March 21, 2025.

Earnings Date	Mar 21, 2025
Ex-Dividend Date	n/a

Share Statistics

KOSDAQ:200230 has 12.03 million shares outstanding. The number of shares has decreased by -20.89% in one year.

Current Share Class	n/a
Shares Outstanding	12.03M
Shares Change (YoY)	-20.89%
Shares Change (QoQ)	+0.00%
Owned by Insiders (%)	0.00%
Owned by Institutions (%)	0.45%
Float	9.19M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.96
PB Ratio	0.45
P/TBV Ratio	0.58
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-3.15
EV / Sales	2.19
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-22.11

Financial Position

The company has a current ratio of 0.37, with a Debt / Equity ratio of 0.67.

Current Ratio	0.37
Quick Ratio	0.27
Debt / Equity	0.67
Debt / EBITDA	12.55
Debt / FCF	-14.85
Interest Coverage	-0.02

Financial Efficiency

Return on equity (ROE) is -28.18% and return on invested capital (ROIC) is -0.03%.

Return on Equity (ROE)	-28.18%
Return on Assets (ROA)	-0.03%
Return on Invested Capital (ROIC)	-0.03%
Return on Capital Employed (ROCE)	-0.08%
Revenue Per Employee	298.15M
Profits Per Employee	-207.24M
Employee Count	127
Asset Turnover	0.26
Inventory Turnover	5.55

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -61.82% in the last 52 weeks. The beta is 0.09, so KOSDAQ:200230's price volatility has been lower than the market average.

Beta (5Y)	0.09
52-Week Price Change	-61.82%
50-Day Moving Average	4,033.60
200-Day Moving Average	5,966.80
Relative Strength Index (RSI)	16.30
Average Volume (20 Days)	25,933

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KOSDAQ:200230 had revenue of KRW 37.87 billion and -26.32 billion in losses. Loss per share was -2,225.00.

Revenue	37.87B
Gross Profit	10.24B
Operating Income	-70.55M
Pretax Income	-26.50B
Net Income	-26.32B
EBITDA	4.44B
EBIT	-70.55M
Loss Per Share	-2,225.00

Full Income Statement

Balance Sheet

The company has 10.04 billion in cash and 55.69 billion in debt, giving a net cash position of -45.65 billion or -3,796.57 per share.

Cash & Cash Equivalents	10.04B
Total Debt	55.69B
Net Cash	-45.65B
Net Cash Per Share	-3,796.57
Equity (Book Value)	83.13B
Book Value Per Share	6,888.10
Working Capital	-43.71B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.22 billion and capital expenditures -4.97 billion, giving a free cash flow of -3.75 billion.

Operating Cash Flow	1.22B
Capital Expenditures	-4.97B
Free Cash Flow	-3.75B
FCF Per Share	-311.76

Full Cash Flow Statement

Margins

Gross margin is 27.03%, with operating and profit margins of -0.19% and -69.51%.

Gross Margin	27.03%
Operating Margin	-0.19%
Pretax Margin	-69.98%
Profit Margin	-69.51%
EBITDA Margin	11.72%
EBIT Margin	-0.19%
FCF Margin	n/a

Dividends & Yields

KOSDAQ:200230 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	20.89%
Shareholder Yield	20.89%
Earnings Yield	-71.30%
FCF Yield	-10.16%

Stock Splits

The last stock split was on December 10, 2024. It was a reverse split with a ratio of 0.1.

Last Split Date	Dec 10, 2024
Split Type	Reverse
Split Ratio	0.1

Scores

KOSDAQ:200230 has an Altman Z-Score of -1.04. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.04
Piotroski F-Score	n/a